Skip to content
Billionaires Digest
My team

PeoplePublic Stake Value as of Nov 11, 2026

No. 27 by Public Stake Value · AI & tech

Peter Thiel

Facebook, Investments
Public Stake Value
$346.8M
Disclosed US-listed shares × latest close. Not a net worth. As of Nov 11, 2026.
Open the live card →

Latest moves

Peter ThielEarningsAI & techPLTRAI read · ▲ Milestone

Palantir's US commercial sales top government sales for first time

The move

Palantir's third-quarter revenue rose 95.9% to $2.31 billion. US commercial revenue jumped 148% to $984 million, overtaking US government revenue of $953 million for the first time in the company's history. The company raised its full-year 2026 revenue outlook to about $8.53 billion.

Why it matters

The milestone shows Palantir, co-founded and chaired by Peter Thiel, successfully shifting from a government-contractor reputation toward winning corporate AI customers.

The bear case

Despite the beat, Palantir's stock traded lower than before the report, as some investors questioned whether its valuation already prices in years of future growth.

What to watch

Palantir's next earnings report, expected in February, will show whether commercial revenue keeps outpacing government work.

Peter ThielIPO / MarketsAI & techPLTRAI read · ▼ Commercial crossover

Palantir's US commercial sales top government revenue for first time

The move

Palantir reported third-quarter revenue of $2.31 billion, above the $2.18 billion analysts expected, with adjusted EPS of 44 cents versus 41 cents expected. U.S. commercial revenue rose 148% to $984 million, surpassing U.S. government revenue of $953 million for the first time in the company's history. Palantir raised its full-year 2026 revenue outlook to about $8.53 billion and projected roughly $2.65 billion in fourth-quarter revenue. Shares still dipped about 3% in after-hours trading. Peter Thiel remains Palantir's largest individual shareholder.

Why it matters

The shift toward commercial customers matters because it shows Palantir's AI software is finding buyers beyond its original base of government and defense contracts, a key test of whether its growth can keep scaling.

The bear case

The stock fell anyway, a sign that after Palantir's huge run-up this year, even a beat-and-raise quarter isn't enough to satisfy a valuation priced for near-perfect execution.

What to watch

Whether commercial revenue keeps outpacing government revenue when Palantir reports in early 2027.

Peter ThielPolicyAI & techPLTRAI read · ▲ Overhang removed, not a new contract

Palantir settles London lawsuit over scrapped police deal

The move

Palantir and the Mayor of London's Office for Policing and Crime (Mopac) settled, on Oct. 14, the lawsuit Palantir had brought after Mopac blocked a roughly £50 million deal for the Metropolitan Police to use Palantir's AI-driven crime-analysis software. Both sides withdrew their allegations against each other. Palantir had argued the block was an unlawful veto based on the firm's "values and ethics"; Mopac said its decision rested on procurement process, not on Palantir specifically. The Met has opened a fresh competition for the analytics contract.

Why it matters

The settlement clears Palantir to compete again for a UK police contract it had been shut out of, at a time when the firm is also facing a separate review of an NHS contract in Britain.

The bear case

Palantir isn't guaranteed to win the re-opened competition, and UK scrutiny of its government contracts continues on other fronts.

What to watch

The outcome of the Met's new procurement competition for the analytics contract.

Peter ThielMarketsAI & techPLTRAI read · ▼ Valuation reset

Palantir drops 7.2% as AI-financing doubts spread

The move

Palantir shares fell 7.22% on October 16 to $186.03, part of a broader software-sector selloff. ServiceNow and Salesforce also dropped as investors questioned how the AI infrastructure buildout will be financed. The stock closed about 11% below the record high it set October 9.

Why it matters

Palantir has been one of the most richly valued AI stocks this year, so it's a bellwether for how investors are pricing the risk that heavy AI spending doesn't pay off on schedule.

The bear case

The drop tracks a sector-wide move, not a Palantir-specific setback, and Goldman Sachs upgraded the stock to Buy with a $230 target just days earlier.

What to watch

Palantir's third-quarter earnings, November 2.

Source · 24/7 Wall St.Read original ↗Report an error
Peter ThielIPO / MarketsAI & techPLTRAI read · ▲ Street turns bullish

Goldman Sachs upgrades Palantir to buy

The move

Goldman Sachs upgraded Palantir from Neutral to Buy on October 8, setting a $230 price target, about 18% above the stock's prior close. Analyst Gabriela Borges cited demand for sovereign AI, bespoke government and enterprise applications, and Palantir's industry-focused strategy. Shares rose as much as 2.5% in premarket trading the next session, nearing a 10-month high.

Why it matters

The upgrade reflects growing Wall Street confidence in Palantir's AI-driven government and enterprise business heading into its next earnings report.

The bear case

Palantir already trades at a rich valuation relative to earnings, and one upgrade doesn't resolve long-standing questions about how much growth is already priced in.

What to watch

Palantir's next quarterly earnings report.

Peter ThielMarketsAI & techPLTRAI read · ▲ Bulls pile in

Goldman Sachs upgrades Palantir to Buy on sovereign AI demand

The move

Goldman Sachs analyst Gabriela Borges upgraded Palantir to Buy from Neutral on Thursday, October 8, with a 12-month price target of $230, implying about 18% upside from Wednesday's close of $194.12. The call cites demand for sovereign AI, bespoke AI systems and Palantir's forward-deployed engineering model. Shares rose 1.8% to $197.53 Thursday, outperforming a falling market (the S&P 500 fell 0.47%, the Nasdaq fell 1.25%).

Why it matters

Palantir is chairman and major shareholder Peter Thiel's biggest publicly traded position; a bullish turn from a major bank adds to the stock's case after a lagging year against the Nasdaq 100.

The bear case

Palantir still trades at a rich multiple on revenue growth that has to keep accelerating; one upgrade doesn't resolve the valuation debate, and Zacks Research cut its own rating to Hold around the same time.

What to watch

Palantir's next quarterly report for whether sovereign and government deals keep growing as fast as Borges expects.

Recent SEC filings

No SEC filings in the last 90 days.

Form 4 insider trades post within 2 business days. 13F fund holdings can arrive 45 days after quarter end. New to filings? Read Filings 101.

Footprint

Companies

Palantir Technologies Inc.PLTR · NASDAQ · Co-founder, director · 4.5% · as of Sep 2024 · ▲ 2.71%
More
Ticker
PLTR
Exchange
NASDAQ
Role
Co-founder, director; one of three founders controlling the Founder Voting Trust (all 1,005,000 Class F shares; ~27.7% of voting power for director elections)
Stake
4.5% of Class A beneficially (100,335,000 sh) — below 5% threshold
Stake as of
2024-09-30
source ↗
Palantir — March 2, 2026 sale of 1,999,980 shares at ~$141-$147 under 10b5-1 plan adopted 2025-11-14; indirect holdings after: Rivendell 7 LLC 34,260,451 sh, PLTR Holdings LLC 20,823,993 sh, Rivendell 25 LLC 53,487 shPLTR · NASDAQ · director · as of Mar 2026 · ▲ 2.71%
More
Ticker
PLTR
Exchange
NASDAQ
Role
director (Form 4)
Stake as of
2026-03-02
source ↗
Founders Fund (venture capital; numerous fund entities on EDGAR e.g. Founders Fund IX, LP CIK 0001971631, Founders Fund Growth IV, LP CIK 0002112131)Co-founder and general partner
source ↗
Mithril Capital (Mithril LP / Mithril II LP and GPs) — joint 10% owner filer with Thiel on Fractyl Health (GUTS) Form 3affiliated investment firm · as of Feb 2024
More
Role
affiliated investment firm (Thiel listed as reporting owner)
Stake as of
2024-02-01
source ↗

Stakes

Stripe (private; valued at $159B as of Feb 2026)undisclosed · as of Feb 2026
source ↗
SpaceX (private; Forbes notes planned 2026 IPO at ~$1.75T valuation)undisclosed · as of 2026
source ↗
Meta Platforms — sold most of stake; left board 2022META · small/unspecified · as of 2022 · ▲ 0.11%
source ↗
Chemomab Therapeutics Ltd. (ADS) — 22,631,200 ordinary shares, 4.6%, via Rivendell Investments 2017-9 LLC4.6% · as of Dec 2025
source ↗
Fractyl Health, Inc. — ~6.08M common-equivalent shares via Mithril entities (10% owner at IPO, Feb 2024)GUTS · >10% · as of Feb 2024 · ▲ 7.81%
More
Ticker
GUTS
Stake
>10% at IPO
Stake as of
2024-02-01
source ↗
PropertyGuru Group — fully exited (0 shares) via BTN Investments 2 LLC0% · as of Dec 2024
source ↗

Investment vehicles

Rivendell 7 LLC / Rivendell 25 LLC / PLTR Holdings LLC / STS Holdings II LLCholding co
More
Type
holding co
Notes
Thiel-controlled LLCs holding Palantir stock (Thiel sole beneficial owner per Form 4 footnotes)
source ↗
Rivendell Investments 2017-9 LLCholding co
More
Type
holding co
Notes
holds Chemomab position
source ↗
BTN Investments 2 LLCholding co
More
Type
holding co
Notes
held PropertyGuru stake (exited by 2024-12-31)
source ↗
Founders Fund IX, LPfund · CIK 0001971631
More
Type
fund
Notes
Founders Fund flagship fund entity on EDGAR (Form D filer); 13F status not checked
source ↗

Real estate

Buenos Aires, Argentina (listed residence)residence · as of 2026-09
source ↗

Giving

Thiel Foundation (Thiel Fellowship: $100,000 over two years to skip college)
source ↗

Prices via Finnhub · as of Nov 11, 2026 12:23 PM ET. For information only.

What to watch

Further Palantir sales under the 10b5-1 plan adopted 2025-11-14 (Form 144/Form 4 filings)
source ↗
SpaceX IPO (Forbes: planned 2026 public offering at ~$1.75T) — Founders Fund/Thiel are holders2026
source ↗
Any change to Palantir Founder Voting Trust / Class F arrangements (disclosed in proxy)
source ↗